Luther King Capital Management (LKCM)’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.68M Buy
47,084
+27,084
+135% +$3.53M 0.02% 258
2025
Q4
$2.43M Hold
20,000
0.01% 329
2025
Q3
$2.24M Buy
+20,000
New +$2.34M 0.01% 333
2022
Q1
Sell
-71,575
Closed -$1.37M 636
2021
Q4
$1.37M Hold
71,575
0.01% 366
2021
Q3
$2.37M Hold
71,575
0.01% 285
2021
Q2
$2.38M Buy
71,575
+21,970
+44% +$609K 0.01% 303
2021
Q1
$2.06M Buy
+49,605
New +$1.53M 0.01% 297

Other funds holding TMDX

Luther King Capital Management (LKCM)'s TMDX Position: Q1 2026 in Review

Luther King Capital Management (LKCM) increased its Transmedics (TMDX) stake by 135% in Q1 2026, buying an estimated $3.53M and bringing the position to 47,084 shares worth $4.68M. The position accounts for 0.02% of the portfolio, ranked #258.

Luther King Capital Management (LKCM) first reported a position in TMDX in Q1 2021 and has held it in 7 quarters since. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Luther King Capital Management (LKCM) held 47,084 shares of Transmedics worth $4.68M as of Q1 2026.
  • Luther King Capital Management (LKCM) bought 27,084 Transmedics shares in Q1 2026, an estimated $3.53M.
  • Transmedics made up 0.02% of Luther King Capital Management (LKCM)'s portfolio in Q1 2026, its #258 holding.
  • Luther King Capital Management (LKCM) first reported a position in Transmedics in Q1 2021 and has held it in 7 quarters since.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q1 2026, filed 11 May 2026.